BATHGATE, UK

With nearly 25 years of experience, our Bathgate location in Scotland, UK is an integral part of Catalent’s European clinical supply services network. This 141,000 sq. ft. facility has a comprehensive range of capabilities to support sponsors’ studies throughout the UK, Europe and beyond, including clinical supply management, FastChain® demand-led supply, clinical-scale commercial packaging, and QP release services.

We have high-speed, automated primary packaging for blisters, as well as semi-automated primary packaging for bottles. We offer packaging design services on site, as well as secondary packaging and clinical labeling services.

Our facility is well-equipped to manage cold chain requirements, with storage environments including 15 to 25°C, 2 to 8°C, -15 to -25°C, and -40 to -80°C, and with additional temperatures to be added, including cryogenic. We also have cold room packaging, as well as low humidity packaging.

In addition to end-to-end clinical supply services, our Bathgate location also works closely with our sister facility in Nottingham to provide integrated development solutions, to help reduce project complexity and risk, and accelerate products to clinic and market.

CAPABILITIES:

• Clinical Supply Management
• Comparator Sourcing
• Primary Packaging
• Secondary Packaging & Labeling
• QP Release
• Cold Chain Services
• Clinical Storage
• Controlled Drug Storage
• Global Distribution
• Returns & Destruction
• Demand-Led Supply
• Direct-to-Patient (Site-to-Patient only)

ACCREDITATIONS

• MHRA Approved

SALES INQUIRIES

CAREERS

We recognize talent is our most important asset. To explore a career with Catalent, visit our Careers Section to submit your resume.

GENDER PAY GAP REPORT

Catalent CTS (Edinburgh) Limited (“Catalent CTS”)continues to be an organisation committed to the growth, development, and engagement of our people, within an inclusive culture. As a UK based organisation of over 250 employees, we now report our gender pay data. Please download here.

CATALENT UK TAX STRATEGY

The purpose of this statement is to satisfy the UK legislative requirements of Schedule 19 Finance Act 2016 in relation to the publication of tax strategy insofar as it affects the UK companies in the Catalent group for the year ended 30 June 2024. Please download here.